Why the study?
Longitudinal data on right ventricular dysfunction and reverse cardiac remodeling in patients following transcatheter edge-to-edge mitral valve repair were scarce.
Does impaired RV-PA coupling (TAPSE/PASP ratio < 0.36) predict worse outcomes in patients undergoing M-TEER for mitral regurgitation?
Does impaired RV-PA coupling (TAPSE/PASP ratio < 0.36) predict worse outcomes in patients undergoing M-TEER for mitral regurgitation?
Impaired RV-PA coupling (TAPSE/PASP < 0.36) is a strong independent predictor of mortality and heart failure hospitalization in patients undergoing M-TEER for mitral regurgitation.
Answers are grounded in this paper and cite their sources.
May warrant intensified post-M-TEER surveillance; leaves open whether RV-PA coupling is a modifiable target.
BACKGROUND: Right ventricular-to-pulmonary artery (RV-PA) coupling has recently been shown to be associated with outcome in valvular heart disease. However, longitudinal data on RV dysfunction and reverse cardiac remodeling in patients following transcatheter edge-to-edge mitral valve repair (M-TEER) are scarce. METHODS: Consecutive patients with primary as well as secondary mitral regurgitation (MR) were prospectively enrolled and had comprehensive echocardiographic and invasive hemodynamic assessment at baseline. Kaplan-Meier estimates and multivariable Cox-regression analyses were performed, using a composite endpoint of heart failure hospitalization and death. RESULTS: Between April 2018 and January 2021, 156 patients (median 78 y/o, 55% female, EuroSCORE II: 6.9%) underwent M-TEER. On presentation, 64% showed impaired RV-PA coupling defined as tricuspid annular plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP) ratio < 0.36. Event-free survival rates at 2 years were significantly lower among patients with impaired coupling (57 vs. 82%, p < 0.001), both in patients with primary (64 vs. 91%, p = 0.009) and secondary MR (54 vs. 76%, p = 0.026). On multivariable Cox-regression analyses adjusted for baseline, imaging, hemodynamic, and procedural data, TAPSE/PASP ratio < 0.36 was independently associated with outcome (adj.HR 2.74, 95% CI 1.17-6.43, p = 0.021). At 1-year follow-up, RV-PA coupling improved (TAPSE: ∆ + 3 mm, PASP: ∆ - 10 mmHg, p for both < 0.001), alongside with a reduction in tricuspid regurgitation (TR) severity (grade ≥ II: 77-54%, p < 0.001). CONCLUSIONS: TAPSE/PASP ratio was associated with outcome in patients undergoing M-TEER for primary as well as secondary MR. RV-PA coupling, alongside with TR severity, improved after M-TEER and might thus provide prognostic information in addition to established markers of poor outcome.
No takes yet. Share an insight, caveat, or question.
Koschutnik et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: